Preimplantation genetic testing for aneuploidy (PGT-A) is one of the most debated add-ons in modern IVF. At $3,000 to $6,000 per cycle, it promises to identify chromosomally normal embryos before transfer — potentially reducing miscarriage risk and shortening time to pregnancy. But is it right for everyone?
What PGT-A Actually Tests
PGT-A screens embryos for the correct number of chromosomes (46 in a healthy embryo). Aneuploidy — having too many or too few chromosomes — is the leading cause of IVF failure, early miscarriage, and conditions like Down syndrome (trisomy 21).
The test involves removing 5-10 cells from the trophectoderm (the outer layer that becomes the placenta) at the blastocyst stage, typically day 5 or 6. These cells are sent to a genetics laboratory for analysis, and results return in 1-2 weeks.
The Real Cost Breakdown
| Component | Cost Range | Notes |
|---|---|---|
| Embryo biopsy (clinic fee) | $1,500–$2,500 | Per cycle, regardless of embryo count |
| Genetic lab analysis | $1,500–$3,500 | Often per embryo or tiered pricing |
| Embryo freezing | $1,000–$1,500 | Required — results take 1-2 weeks |
| Frozen embryo transfer | $3,000–$5,000 | Separate cycle for transfer |
| Total added cost | $4,000–$6,500 | Above base IVF cycle |
Some clinics bundle PGT-A into package pricing. Insurance coverage is rare but expanding — check if your plan covers "genetic testing" or "chromosomal screening" separately from IVF itself.
Who Benefits Most
ASRM's 2024 committee opinion acknowledges PGT-A can improve per-transfer success rates but notes it has not been definitively shown to improve cumulative live birth rates in all patient populations. The evidence is strongest for:
- Women 38+: Aneuploidy rates rise sharply with age — over 60% of embryos may be aneuploid by age 40, and over 80% by age 43
- Recurrent pregnancy loss: Patients with 2+ unexplained miscarriages, where aneuploidy may be the underlying cause
- Repeated implantation failure: When 3+ morphologically good embryos have failed to implant
- Known chromosomal concerns: Either partner carries a balanced translocation or other structural abnormality
The Controversy
PGT-A is not without legitimate criticism:
Mosaicism: Some embryos labeled "abnormal" are actually mosaic — containing a mix of normal and abnormal cells. A percentage of mosaic embryos can self-correct during development and result in healthy babies. Discarding them means potentially losing viable embryos.
Biopsy risk: While generally considered safe, trophectoderm biopsy is an invasive procedure. Some studies suggest a small (1-2%) reduction in implantation potential from the biopsy itself.
False results: No genetic test is 100% accurate. False positives (normal embryos called abnormal) and false negatives (abnormal embryos called normal) both occur at low rates.
Questions to Ask Before Testing
- How many embryos do I expect to have? (PGT-A is less helpful with very few embryos — you may transfer them all regardless)
- What is my age-specific aneuploidy rate?
- Does your lab report mosaic embryos, and what is your policy on transferring them?
- Which genetics lab do you use, and what is their reported accuracy rate?
- Will PGT-A change your transfer recommendation, or will you transfer my best embryo either way?
The Bottom Line
PGT-A is a powerful tool when used in the right clinical context. It is most valuable for patients over 37, those with recurrent loss, or anyone who wants to minimize the emotional and physical toll of transferring embryos unlikely to succeed. It is less clearly beneficial for younger patients with many embryos who would reach a successful transfer regardless. Discuss your specific situation with your RE before deciding.
Related Reading
- AI Embryo Selection: What Patients Should Know
- IVF Insurance Coverage by State
- Using HSA and FSA for Fertility Treatments
Explore More Resources
Track Your Cycle
OPK comparisons, BBT charts, and timing guides for every cycle type.
FertileStart →Optimize Your Body
Evidence-based supplements, nutrition plans, and lifestyle changes for fertility.
LifeFertile →The Full Picture
Your central hub for fertility news, research updates, and getting started.
HowToHaveABaby →